Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Biological and Pharmaceutical Bulletin | journal | 0.518 Q3 | 134 | 247 | 805 | 8546 | 1578 | 794 | 1.74 | 34.60 | |
52 | Drug Resistance Updates | journal | 4.665 Q1 | 132 | 74 | 76 | 6493 | 1477 | 75 | 17.53 | 87.74 | |
53 | Cancer Biology and Therapy | journal | 0.914 Q2 | 130 | 83 | 267 | 3691 | 956 | 263 | 4.32 | 44.47 | |
54 | European Neuropsychopharmacology | journal | 1.756 Q1 | 130 | 134 | 450 | 6187 | 2034 | 346 | 4.22 | 46.17 | |
55 | Journal of Clinical Pharmacology | journal | 0.717 Q2 | 130 | 195 | 567 | 7254 | 1411 | 510 | 2.46 | 37.20 | |
56 | Apoptosis : an international journal on programmed cell death | journal | 1.427 Q1 | 128 | 111 | 193 | 7674 | 1133 | 179 | 6.12 | 69.14 | |
57 | International Journal of Neuropsychopharmacology | journal | 1.525 Q1 | 125 | 79 | 261 | 4188 | 1265 | 254 | 4.59 | 53.01 | |
58 | Fitoterapia | journal | 0.572 Q3 | 124 | 270 | 667 | 11896 | 2221 | 667 | 2.81 | 44.06 | |
59 | European Journal of Clinical Pharmacology | journal | 0.727 Q2 | 123 | 163 | 626 | 6493 | 1431 | 530 | 2.25 | 39.83 | |
60 | Cancer Chemotherapy and Pharmacology | journal | 0.869 Q2 | 122 | 109 | 496 | 3935 | 1395 | 488 | 2.73 | 36.10 | |
61 | Current Drug Metabolism | journal | 0.453 Q3 | 122 | 69 | 312 | 5722 | 643 | 287 | 2.08 | 82.93 | |
62 | ChemMedChem | journal | 0.761 Q2 | 119 | 211 | 854 | 11840 | 3091 | 842 | 3.65 | 56.11 | |
63 | Current Drug Targets | journal | 0.691 Q2 | 119 | 97 | 390 | 10001 | 1214 | 368 | 2.96 | 103.10 | |
64 | PharmacoEconomics | journal | 1.517 Q1 | 118 | 106 | 332 | 5784 | 1361 | 286 | 3.88 | 54.57 | |
65 | Acta Pharmacologica Sinica | journal | 1.882 Q1 | 117 | 217 | 643 | 13284 | 5055 | 633 | 7.19 | 61.22 | |
66 | Expert Opinion on Investigational Drugs | journal | 1.414 Q1 | 117 | 108 | 354 | 8144 | 1698 | 322 | 4.77 | 75.41 | |
67 | Journal for ImmunoTherapy of Cancer | journal | 3.728 Q1 | 117 | 445 | 1590 | 19408 | 14743 | 1571 | 8.71 | 43.61 | |
68 | Clinical and Experimental Pharmacology and Physiology | journal | 0.610 Q2 | 115 | 93 | 501 | 4340 | 1255 | 488 | 2.42 | 46.67 | |
69 | Steroids | journal | 0.476 Q3 | 114 | 110 | 346 | 6032 | 899 | 342 | 2.28 | 54.84 | |
70 | Journal of Cardiovascular Pharmacology | journal | 0.610 Q2 | 109 | 113 | 574 | 4825 | 1358 | 538 | 2.24 | 42.70 | |
71 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.503 Q3 | 108 | 201 | 723 | 12531 | 2011 | 702 | 2.69 | 62.34 | |
72 | Vascular Pharmacology | journal | 0.969 Q1 | 108 | 66 | 187 | 3575 | 665 | 183 | 3.64 | 54.17 | |
73 | American Journal of Health-System Pharmacy | journal | 0.557 Q3 | 107 | 308 | 1159 | 2543 | 1504 | 937 | 1.09 | 8.26 | |
74 | Inflammation Research | journal | 1.309 Q1 | 107 | 162 | 336 | 10100 | 1863 | 321 | 5.10 | 62.35 | |
75 | Mini-Reviews in Medicinal Chemistry | journal | 0.597 Q2 | 107 | 128 | 492 | 14236 | 1903 | 484 | 3.60 | 111.22 | |
76 | Environmental Toxicology and Pharmacology | journal | 0.864 Q2 | 106 | 242 | 529 | 16630 | 2372 | 524 | 4.73 | 68.72 | |
77 | Expert Opinion on Therapeutic Targets | journal | 1.423 Q1 | 106 | 103 | 274 | 11531 | 1287 | 245 | 3.99 | 111.95 | |
78 | Journal of Immunotherapy | journal | 1.263 Q1 | 106 | 44 | 150 | 1376 | 521 | 149 | 3.12 | 31.27 | |
79 | Expert Review of Vaccines | journal | 1.412 Q1 | 105 | 110 | 409 | 7915 | 2013 | 364 | 5.10 | 71.95 | |
80 | Basic and Clinical Pharmacology and Toxicology | journal | 0.744 Q2 | 103 | 118 | 394 | 4960 | 1109 | 378 | 2.98 | 42.03 | |
81 | Current Cancer Drug Targets | journal | 0.650 Q2 | 103 | 76 | 216 | 5127 | 602 | 211 | 2.34 | 67.46 | |
82 | Current Neuropharmacology | journal | 1.299 Q1 | 103 | 177 | 379 | 22198 | 2240 | 363 | 4.96 | 125.41 | |
83 | Anti-Cancer Drugs | journal | 0.476 Q3 | 102 | 143 | 526 | 4507 | 1045 | 525 | 1.89 | 31.52 | |
84 | Expert Opinion on Biological Therapy | journal | 1.104 Q1 | 102 | 129 | 440 | 8646 | 1740 | 395 | 3.72 | 67.02 | |
85 | Therapeutic Drug Monitoring | journal | 0.591 Q2 | 102 | 116 | 328 | 4136 | 846 | 295 | 2.68 | 35.66 | |
86 | Experimental and Clinical Psychopharmacology | journal | 0.827 Q2 | 101 | 63 | 309 | 3335 | 740 | 308 | 2.43 | 52.94 | |
87 | Journal of Pharmacological Sciences | journal | 0.876 Q2 | 101 | 80 | 324 | 3004 | 1106 | 324 | 3.23 | 37.55 | |
88 | Drug Development and Industrial Pharmacy | journal | 0.475 Q3 | 100 | 71 | 454 | 3365 | 1412 | 454 | 2.31 | 47.39 | |
89 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.987 Q1 | 100 | 87 | 267 | 7118 | 1138 | 252 | 3.84 | 81.82 | |
90 | Journal of AOAC International | journal | 0.393 Q3 | 100 | 170 | 543 | 1757 | 958 | 534 | 1.73 | 10.34 | |
91 | Pharmacogenomics | journal | 0.439 Q3 | 100 | 90 | 325 | 3614 | 522 | 314 | 1.54 | 40.16 | |
92 | Naunyn-Schmiedeberg's Archives of Pharmacology | journal | 0.735 Q2 | 99 | 433 | 532 | 28163 | 1903 | 528 | 3.62 | 65.04 | |
93 | Pharmacological Reports | journal | 0.867 Q2 | 98 | 117 | 404 | 9099 | 1689 | 399 | 3.74 | 77.77 | |
94 | Bulletin of Mathematical Biology | journal | 0.610 Q2 | 97 | 122 | 406 | 6141 | 892 | 403 | 2.14 | 50.34 | |
95 | Investigational New Drugs | journal | 1.086 Q1 | 97 | 95 | 516 | 2870 | 1599 | 511 | 2.92 | 30.21 | |
96 | CNS and Neurological Disorders - Drug Targets | journal | 0.620 Q2 | 96 | 120 | 223 | 12672 | 632 | 207 | 2.79 | 105.60 | |
97 | Canadian Journal of Physiology and Pharmacology | journal | 0.499 Q3 | 95 | 66 | 379 | 2685 | 703 | 372 | 1.75 | 40.68 | |
98 | Pharmacogenomics Journal | journal | 0.659 Q2 | 95 | 28 | 194 | 1215 | 524 | 193 | 2.58 | 43.39 | |
99 | Drug Design, Development and Therapy | journal | 0.999 Q1 | 94 | 271 | 1141 | 13688 | 5855 | 1136 | 4.89 | 50.51 | |
100 | Addiction Biology | journal | 1.154 Q1 | 93 | 95 | 503 | 5373 | 1710 | 498 | 3.32 | 56.56 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®